The effects of antipsychotic therapy on serum lipids: a comprehensive review
- 10 March 2004
- journal article
- review article
- Published by Elsevier in Schizophrenia Research
- Vol. 70 (1) , 1-17
- https://doi.org/10.1016/j.schres.2004.01.014
Abstract
No abstract availableKeywords
This publication has 85 references indexed in Scilit:
- A Study of Quetiapine: Efficacy and Tolerability in Psychotic AdolescentsJournal of Child and Adolescent Psychopharmacology, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- The Apparent Effects of Ziprasidone on Plasma Lipids and GlucoseThe Journal of Clinical Psychiatry, 2001
- Drug-Induced Lipid ChangesDrug Safety, 2001
- Bodyweight Gain with Atypical AntipsychoticsDrug Safety, 2001
- Effects of pharmacological therapy on anthropometric and biochemical status of male and female institutionalized psychiatric patients.Journal of the American College of Nutrition, 1994
- Mortality and Causes of Death in First Admitted Schizophrenic PatientsThe British Journal of Psychiatry, 1993
- Fluperlapine vs Haloperidol: A Comparison of their Neuroendocrinological Profiles and the Influence on Serum LipidsPharmacopsychiatry, 1986
- Decreased concentration of high density lipoprotein cholesterol in schizophrenic patients treated with phenothiazinesAtherosclerosis, 1984
- Hepatic Cholesterol Synthesis in Man: Effect of Diazepam and Other Drugs†European Journal of Clinical Investigation, 1975